Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: RTOG 0920 A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER

 


RTOG 0920 A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER


Trial Focus

Head and Neck Cancers

Objective

         The purpose of this study is to compare the effects, good and/or bad, of radiation therapy alone with radiation therapy and cetuximab cancer to find out which is better. In this study, patients will get either radiation therapy alone OR radiation therapy

IRB Protocol #

10-0095

Trial Status

OPEN

Principle Investigator

DAVID RABEN

Sponsor

RTOG

Contact

MONICA ROBISCHON at (720) 848-0661 or MONICA.ROBISCHON@UCDENVER.EDU

Location

Dept Of Veterans Affairs Medical Center ST. MARYS HOSPITAL - G.J. University of Colorado Hospital Dept Of Veterans Affairs Medical Center ST. MARYS HOSPITAL - G.J. University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period to determine eligibility. A treatment period (s) that can last up to 11 weeks. Patients will be followed for life. // Eligibility criteria include but are not limited to 18 years or older with head and nexk cancer.Eligibility criteria include but are not limited to 18 years or older with head and nexk cancer.